| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
2,915 |
2,743 |
$2.65M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
6,508 |
6,029 |
$223K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,516 |
3,373 |
$186K |
| 92134 |
|
11,114 |
10,567 |
$184K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
234 |
226 |
$178K |
| J9035 |
Injection, bevacizumab, 10 mg |
1,680 |
1,540 |
$109K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,283 |
1,272 |
$106K |
| 92235 |
|
1,878 |
1,856 |
$96K |
| J0177 |
Injection, aflibercept hd, 1 mg |
69 |
67 |
$93K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,669 |
1,639 |
$86K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
2,115 |
2,057 |
$75K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,846 |
1,808 |
$59K |
| 67228 |
|
270 |
219 |
$46K |
| 92250 |
|
1,492 |
1,474 |
$31K |
| 76512 |
|
623 |
532 |
$16K |
| 92201 |
|
851 |
807 |
$11K |
| J3590 |
Unclassified biologics |
312 |
294 |
$8K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
41 |
41 |
$3K |
| 92226 |
|
115 |
83 |
$2K |
| 92225 |
|
43 |
25 |
$612.84 |
| J7999 |
Compounded drug, not otherwise classified |
36 |
35 |
$502.48 |